Axolemma-enriched and myelin-enriched fractions were prepared from bovine CNS white matter and conjugated to ftuorescein isothiocyanate (FITC). Both unlabelled and FITC-labelled axolemma and myelin were mitogenic for cultured rat Schwann cells. Treatment of Schwann cells with the FITC-labelled mitogens for up to 24 h resulted in two distinct morphological appearances. FITC-myelin-treated cells were filled with numerous round, fluorescent-labelled intracellular vesicles, while FITC-axolemma-treated cells appeared to be coated w{th a patchy, ill-defined fluorescence, primarily concentrated around the cell body but extending onto the cell processes. These observations were corroborated under phase microscopy. Electron microscopy revealed multiple, membrane-bound, membrane-containing phagosomes within myelin-treated cells and to a far lesser extent in axolemma-treated cells. The effect on the expression of the myelin-mediated and axolemma-mediated mitogenic signal when Schwann cells were treated with the lysosomal inhibitors, ammonium chloride and chloroquine, was evaluated. The mitogenicity of myelin was reduced 70-80% by these agents whereas the mitogenicity of axolemma was not significantly altered under these conditions. These results suggest that axolemma and myelin stimulate the proliferation of cultured Schwann cells by different mechanisms. Myelin requires endocytosis and lysosomal processing for expression of its mitogenic signal; in contrast, the mitogenicity of axolemma may be transduced at the Schwann cell surface.
Introduction
Schwann cells are known to proliferate in vivo during both neural development (Asbury, 1967; Martin & Webster, 1973 , Terry et al., 1974 and Wallerian degeneration (Fisher & Turano, 1963; Bradley & Asbury, 1970; Thomas, 1970; Romine et al., 1976) . The mechanism of the induction of these proliferative responses has not been elucidated, although each may be mediated by a separate process (Salzer & Bunge, 1980) . Numerous agents have been shown to be mitogenic for cultured Schwann cells, including axolemma-enriched fractions from both the PNS and CNS (DeVries et al., 1982 (DeVries et al., , 1983b , neurites from dorsal root ganglia (Salzer et al., 1980a, b) , pituitary-derived glial growth factor (Raft et al., 1978a; Brockes et al., 1981) , cy.c!ic AMP (Raft et aL~ 1978b) and cholera toxin (Raft et al., 1978a, b) . Myelin has also been shown to be mitogenic for Schwann cells (DeVries et aI., 1982) . Characterization of the neurally-derived mitogens has suggested that they are surface proteins (Salzer et al., 1980b) and require direct contact with the Schwann cell to exert their mitogenic effect (Wood & Bunge, 1975; Salzer et al., 1980b) .
In this report, we demonstrate that the mitogenic signals of axolemma-enriched fractions and myelin preparations are mediated by two distinct pathways. Myelin expresses its mitogenic signal only after endocytosis and lysosomal processing by the cultured Schwann cells. In contrast, the mitogenicity of the axolemma-enriched fraction may be transduced at the Schwann cell surface.
These morphological observations support our previous biochemical evidence for two separate mechanisms for the transduction of the two mitogenic signals by cultured Schwann cells (Yoshino et aI., 1984) . Previously, it has been suggested that the proliferative response of Schwann cells seen in vivo during Wallerian degeneration and neural development may also be mediated by two different signals (Salzer & Bunge, 1980) . The present report supports this suggestion. The demonstration of two distinct pathways for expression of mitogenic signals may represent in vitro models of these two in vivo phenomena in which Schwann cell proliferation is observed.
Materials and methods

Preparation of Schwann cells
Schwann cells were prepared by the method of Brockes et al. (1979) . Briefly, sciatic nerves were removed from 2-3 day rat pups. The nerves were treated with trypsin (Type IX, Sigma) and collagenase (Type III, Worthington), and were then triturated with a pasteur pipette and filtered through 209 Micron Nitex (Tetko, Inc.). The cells were collected by centrifugation and resuspended in Dulbecco's Modified Eagle's Medium (DME) (GIBCO) with 10% foetal calf serum (Sterile Systems). The cells were plated in 100 mm glass dishes at a density of 3-4.5 x 10 6 cells per dish. After 24 h, cytosine arabinoside was added to inhibit fibroblast proliferation (final concentration = 10 -s M). The medium was replaced without cytosine arabinoside after 72 h. After three additional days, the cells were treated with rabbit complement (Cappel Labs) and anti-Thy 1.1 (New England Nuclear), an antibody that is directed against an antigen found on fibroblasts but not Schwann cells, in order to eliminate remaining fibroblasts by complementmediated lysis. The cells were then collected by centrifugation and plated onto 12 mm glass coverslips at a density of 3-5 x 104 cells per slip. These procedures resulted in cultures that were greater than 99.5% Schwann cells, as determined by phase microscopy.
Preparation of axolemma and myelin-enriched fractions
Axolemma and myelin-enriched fractions were prepared as previously reported (DeVries et al., 1978; 1983a, b) . Briefly, 1 g of bovine cervical cord white matter was gently homogenized in buffered salt-sucrose media and centrifuged to obtain a floating layer of myelinated axons which were mechanically and osmotically shocked. The shocked myelinated axon suspension (3 ml) was applied to a 34 ml 1040% linear sucrose gradient and centrifuged at 82 500 • g for 18 h. The gradient was fractionated, and sucrose concentrations of each fraction were determined. Fractions with sucrose concentrations of 17-20% were pooled as myelin-enriched fractions, and fractions of 27-32% sucrose concentration were pooled as axolemma-enriched fractions. The sucrose used in all preceding steps contained 0.02% (w/v) azide. These fractions were then either treated with fluorescein isothiocyanate (FITC) (see below), or were centrifuged at 82 500 x g for 1 h and the pellet resuspended in 1-2 ml of sterile 138 mM NaC1, 5.4 mM KC1, 1.1 mM Na2PO4, 1.1 mM KH2PO4 and 22 mM dextrose, pH 7.0 (saline I) to a concentration of approximately 1 mg protein m1-1, and frozen at -200 C in small aliquots. Protein was determined by the method of Bradford (1976) , with ~-globulin as the standard.
Preparation of FITC-labeUed membranes
Pooled membrane fractions as prepared above were conjugated to FITC as outlined by Pearse (1980) . In brief, 8 ml (3-4 mg protein) of membrane suspension were treated with a sodium carbonate buffer (final concentration = 0.075 M; pH 9.0) at 4 ~ C. Solid FITC powder (1 mg) was added, and the mixture stirred overnight at 4 ~ C. An equal volume of isotonic saline was added and the resulting suspension was centrifuged at 82 500 x g for i h. The resulting pellet was resuspended in 1-2 ml sterile saline I to a concentration of 1-2 mg protein m1-1, and frozen at -20 ~ C in 100-200 ~1 aliquots.
Light level radiography
Schwann cell-plated coverslips were contained in Linbro plates which had 24 individual wells; each well contained 500 ~1 DME plus 10% foetal calf serum. Mitogens and, in some experiments, sterile-filtered solutions of ammonium chloride (NH4C1) or chloroquine were added 24 h after plating. These agents were diluted in sterile DME plus 10% foetal calf serum to the desired concentrations. After a further 24 h, 1.5 ~Ci of [3HI thymidine (19.3 Ci mmo1-1, New England Nuclear) were added. The total final volume was 712.5 ~1, unless otherwise noted. The cells were fixed in 2% paraformaldehyde 48 h after the addition of thymidine, then dehydrated in graded alcohols and mounted onto slides. The slides were dipped in NTB-2 emulsion (Eastman Kodak) which was diluted 1:2 in water, then dried and stored in the dark at 4 ~ C for 3-4 days. They were developed, fixed, and stained with haematoxylin and eosin. A minimum of 500 cells were evaluated on each coverslip and the labelling index was calculated (labelled cells/total cells x 100). A cell was considered labelled if more than 20 grains were observed over the nucleus. This method has been previously described (DeVries et al., 1982 (DeVries et al., , 1983a .
Light level microscopy
Fluorescence and phase contrast micrographs were obtained on a Zeiss photomicroscope III using the built-in automatic camera. Kodak Tri-X film exposed at 2000 ASA was used for photographs. Fluorescent images were obtained using a halogen light source, an exciter filter (450-490 nm), diachromic mirror (510 nm) and barrier filter (520 nm) incorporated into the microscope.
Electron microscopy
For electron microscope studies, Schwann cells were plated onto 12 mm Aclar discs at a density of 5.0 x 104 cells per disc. The cells were treated with either axolemma, myelin (14 ~g protein m1-1 of media) or media alone. After 24 h, the cultures were rinsed with saline I, fixed for 2 h in 2% glutaraldehyde in saline I and post-fixed in 2% aqueous osmium tetroxide for 1 h. The cells were dehydrated with graded alcohols, infiltrated and embedded directly in PolyBed 812 epoxy resin. During the polymerization of the resin, the discs were placed in flat embedding mold with the cell side down. Areas of the disc containing cells were cut out and mounted on lucite stubs, then trimmed and sectioned en face with a Sorvall Porter-Blum MT-2 ultramicrotome. Silver-gold sections were stained with uranyl acetate and lead citrate and examined with a Hitachi HU-12 electron microscope.
Other methods
Polyacrylamide gel electrophoresis was performed as previously described by Bigbee et al. (1985) ; 50 ~g of protein per sample was subjected to electrophoresis. Rat liver microsomes were prepared by the method of Neville (1968) .
Statistical analyses
Student's t-test was used for all statistical analyses, with P ( 0.05 used to define significance.
Results
Characterization of FITC-conjugated membranes
To ensure that FITC-conjugation had not altered the activity of the axolemma and myelin-enriched fractions, the mitogenic activity of both unlabelled and FITC- Table 1 . Effect of FITC-conjugation on the mitogenicity as measured by radioautography of bovine CNS axolemma and myelin-enriched fractions.
Sample [3H] thymidine-Iabelled nuclei (%)
Control (no mitogen added) 1.4 + 0.2 Axolemma 25.6 + 3.9 FITC-axolemma 27.6 + 1.6 Myelin 14.9 + 1.0 FITC-myelin 12.8 + 2.1
Values reported are mean percentages of two slides (500 cells counted each) + S.E.M. Final mitogen concentration = 14 lzg protein ml 1 of media. Schwann cells were plated onto glass coverslips at a density of 28 000 cells per slip, and were treated with FITC-myelin (14 ~g ml -i) in DME + 10% foetal calf serum for 24 h. The slips were rinsed once, placed on a glass slide and examined. Note multiple, sharply outlined, discrete intracellular inclusions. Scale bar = 5 btm. x 1800. conjugated membranes was determined by their ability to promote [3H] thymidine incorporation into Schwann cells as measured by light-level radioautography (DeVries et al., 1982 (DeVries et al., , 1983a . As shown in Table 1 , the labelling indices ranged from 14.9% for myelin to 25.6% for axolemma; no statistically significant difference in mitogenicity was noted following FITC-treatment of the membranes. Rat liver microsomes have been previously shown not to be mitogenic for cultured Schwann cells (DeVries et al., 1983a) . Rat liver microsomes were conjugated with FITC and were found to have a labelling index of 1.7%, i.e. not significantly different from control wells with no added mitogen (data not shown). To determine which components of the axolemma and myelin preparations had been labelled with FITC, samples of both were electrophoresed on polyacrylamide gels. Fluorescence was evenly distributed among the separated polypeptides and the lipids which migrated with the dye front (data not shown), indicating that the conjugation procedure resulted in uniform and nonspecific labelling of all the molecular components of axolemma and myelin.
Nature of the interaction between Schwann cells and FITC-labelled membranes
Exposure of Schwann cells to FITC-labelled axolemma and myelin-enriched fractions resulted in two very different morphological appearances. In cells treated with labelled myelin, there appeared to be numerous sharply circumscribed areas of fluorescence concentrated in the Schwann cell body (Fig. 1A) ; at least 95% of the Schwann cells on the coverslip were so labelled. Examination of such cells under phase microscopy (Fig. 1B) revealed that the cells were filled with numerous structures that appeared vacuole-like. It was reasonable to conclude that these areas of fluorescence were indeed intracellular membrane-bound vesicles (phagosomes) for several reasons. First, the areas always appeared to be within the confines of the Schwann cell plasma membrane; if they were labelled membranes adhering to the cell surface, one would expect to see instances where these fluorescent areas would appear to protrude beyond the cell membrane. Second, these areas of fluorescence appeared identical to what has been previously described as intracellular vesicles filled with FITC-labelled proteins in other cell lines (Easty & Trowell, 1965; Rhodes & Lind, 1968; Wild, 1970 Wild, , 1973 . Third, various investigators have used electron microscopy to demonstrate membranes in Schwann cell phagosomes during Wallerian degeneration (Satinsky et al., 1964; Holtzman & Novikoff, 1965; Berner et aI., 1973) , supporting the contention that Schwann cells can phagocytose myelin.
Schwann cells treated with FITC-labelled axolemma were characteristically different from myelin-treated cells ( Fig. 2A, B) . Examination with fluorescence microscopy ( Fig.  2A) revealed that the axolemma appeared as a highly irregular and ill-defined fluorescent area, with the fluorescence at its highest concentration around the cell body but also continuing well onto the cell processes. The fluorescence was not confined to within the boundary of the cell outline and gave the appearance of membrane fragments coating the exterior of the Schwann cell. At least 95% of the cells on the coverslip manifested this appearance. Under phase microscopy ( Fig. 2B) , aggregates of membranes could be observed surrounding and apparently in contact with the Schwann cells, correlating well with the fluorescent image. Areas of fluorescence which had the appearance of the phagosomes previously seen in myelin-treated cells could occasionally be found in axolemma-treated cells.
To determine if either of these phenomena was specific for the given membrane preparation, rat liver microsomes were prepared and conjugated to FITC in the same manner as the axolemma and myelin. When Schwann cells were treated with microsomes at similar concentrations, a pattern similar to that seen in myelin-treated ceils was observed. Only 20-25% of the Schwann cells on the coverslip manifested the intracellular inclusions (data not shown), however, and there were substantially fewer phagosomes per labelled cell than in the case of myelin-treated cells. This is in agreement with a previous report (Salzer et al., 1980a) in which Schwann cells were observed to phagocytose various membranes nonspecifically.
A control preparation of Schwann cells was treated with a solution of FITC only. Under the conditions used for observing the membrane-treated cells, FITC was not observed to interact with the cells at all.
Electron microscopy of mitogen-treated Schwann cells
To determine if the areas of fluorescence seen in FITC-myelin treated cells were indeed intracellular and to attempt to study further the nature of the axolemma-Schwann cell interaction, mitogen-treated Schwann cells were examined by electron microscopy. In axolemma-treated cells unilamellar membrane vesicles of various sizes were observed in close proximity to Schwann cells (Fig. 3B ), but only rarely were they observed to be in direct contact with the cell. The interaction of these vesicles that was seen by light-level microscopy may have been disrupted by processing for electron microscopy, or the points of contact may have been out of the plane of the thin sections taken for electron microscopy.
Axolemma-treated cells contained occasional intracellular phagosomes (data not shown). In contrast to the axolemma-treated Schwann cells, myelin-treated cells displayed numerous membrane-bound vesicles containing electron-dense membranes (Fig. 4A) . At higher magnification (Fig. 4B) , these dense membranes were observed to be multilamellar. The periodicity between major dense lines measured 11-35 nm which agreed well with the reported periodicity of 12-18 nm for the myelin membrane in situ (Raine, 1977) . Control cells with no mitogen exposure (Fig. 3A) contained no membrane-bound vesicles. The morphological characteristics were similar to those recently reported for cultured Schwann cells (Fields & Raine, 1982) .
Effect of lysosomal inhibitors on mitogenic signals
To determine if the phagocytosis of myelin and axolemma was associated with their mitogenicity, Schwann cells were treated with axolemma-and myelin-enriched fractions in the presence and absence of the lysosomal inhibitors, NH4C1 and chloroquine. These agents appear selectively to elevate pH within the lysosome while not affecting cytoplasmic pH (Poole & Ohkuma, 1981) , thus diminishing lysosomal enzyme function. These agents have been studied in numerous cell systems and have been shown to inhibit protein degradation (Seglen, 1975; Seglen & Reith, 1976; Rote & Rechsteiner, 1983) and glycosaminoglycan turnover (Glimelius et aI., 1977) . They have been implicated in inhibiting endocytosis as well as lysosomal function (Sandvig et al., 1979; Tietze et aI., 1980) .
The results of these experiments are summarized in Figs 5 and 6. Increasing doses of NH4C1 (Fig. 5) caused a steady and significant reduction of [3H] thymidine incorporation into Schwann cells in myelin-treated preparations. At doses as low as 6 mM NH4C1, the myelin mitogenic signal as measured by radioautography was reduced by 44% (P < 0.001). At 12 mM (the highest dose tested), the myelin mitogenic signal was reduced by 71% (P < 0.001). Schwann cells treated with axolemma-enriched fraction showed no significant decrease in the labelling index when treated with concentrations of NH4C1 which significantly inhibited the mitogenic response of cultured Schwann cells to myelin.
Similar results were obtained when axolemma and myelin-treated Schwann cells were subjected to chloroquine (Fig. 6) . No significant change in the level of mitogenic activity was noted when axolemma-treated cells were exposed to chloroquine. Myelin-treated cells showed a significant (P < 0.01) reduction in labelled nuclei at chloroquine concentrations as low as 4 ~M, with a 73% decrease in mitogenic activity at 6 ~tM (P < 0.001). Control preparations, i.e. Schwann cells treated with or without the lysosomal inhibitors in the absence of axolemma or myelin, consistently had a labelling index of less than 0.2%.
Examination of Fig. 6 suggests that the axolemma-treated cells experience a reduction in mitogenic intensity as chloroquine concentration increases. To determine if this apparent trend ever becomes significant, higher concentrations of chloroquine were applied in a separate experiment. A chloroquine concentration of 14 ~M caused a highly significant (P < 0.001) 60% decrease in the myelin mitogenic signal, from 13.7 + 1.4% to 5.7 + 0.7%; the axolemma signal was only reduced from 17.7 + 2.4% to 14.5 + 1.6% (not significant). Higher concentrations of chloroquine were cytotoxic for the Schwann cells.
Discussion
We have demonstrated that axolemma-enriched and myelin-enriched fractions stimulate cultured Schwann cell proliferation by different mechanisms. Myelin was endocytosed, contained in vacuoles (phagosomes) and required lysosomal processing by the Schwann cell for expression of its mitogenic activity. Axolemma, however, appeared under Schwann cells were plated on glass coverslips at a density of 38 000 cells per slip, and were processed for radioautography as described in text. Axolemma (A) and myelin (M) concentrations were 7 ~g m1-1. Results are expressed as the means _+_ S.E.M. * indicates P < 0.01 when compared to control (NH4C1 = 0).
light-level microscopy to interact with Schwann cells at the cell surface for prolonged periods. Lysosomal processing was not required for the expression of the mitogenicity of axolemma-enriched fractions, even though electron microscopy showed that some endocytosis had occurred. Phagocytosis of membranes did not appear to be a stimulus for mitogenicity, in agreement with a previous report (Salzer et at., 1980b) , inasmuch as liver microsomes were not mitogenic. Lysosomal processing, however, did appear to be a specific requirement for the expression of the mitogenic activity of myelin, as inhibition of lysosomal function diminished the mitogenicity of myelin but spared that of axolemma. The reduction by 71-73% of the myelin mitogenic signal was in close agreement with reports of lysosomal inhibition in other systems. Lysosomal protein degradation has been reported to be decreased by up to 75-80% by similar doses of chloroquine and NH4C1 (Seglen, 1975; Seglen & Reith 1976; Rote & Rechsteiner, 1983) ; glycosaminoglycan turnover in glial cells has been reported to be altered by 67% (Glimelius et al., 1977) . The observed endocytosis and lysosomal processing of myelin as a stimulus for Schwann cell proliferation is consistent with observations that have been made during Wallerian degeneration. Schwann cells proliferate during degeneration with a maximal response by the third day following lesioning (Friede & Johnstone, 1967) . Concomitant with Schwann cell mitosis, phagocytosis of debris including myelin is observed (Satinsky et al., 1964) . The source of the phagocytic cells seen in vivo has been the subject of controversy, but most recent investigations have indicated that the Schwann cell itself ingests the myelin (Holtzman & Novikoff, 1965; Salzer et al., 1980b) . Further, several investigators have implicated lysosomal activation during degeneration by measuring various marker enzymes (Fisher & Turano, 1963; Holtzman & Novikoff, 1965) .
Our results indicate that myelin is a stimulus for Schwann cell mitosis, and the lysosomal function must be intact for expression of the mitogenic signal. These findings are consistent with those of other investigators who suggested that the breakdown of myelin by cultured Schwann cells may be the trigger for mitosis (Salzer & Bunge, 1980) . Phagocytosis and lysosomal processing of myelin debris may be required during Wallerian degeneration in order for Schwann cells to proliferate. On the other hand, Beuche & Friede (1984) concluded that Schwann cell proliferation characteristic of Wallerian degeneration did not occur when non-resident cells (i.e. macrophages) were excluded from the site of the lesion. This conclusion was based on the observation of mouse peripheral nerves which had been transplanted into Millipore diffusion chambers (containing pores which either excluded or allowed infiltration of non-resident cells) which were implanted into the peritoneal cavity. These disparate findings may be reconciled by considering that the present study utilized Schwann cells prepared from neonatal animals which had become mitotically quiescent, whereas Beuche & Friede utilized mature, fully differentiated Schwann cells which had produced a myelin sheath. In addition, the model used by Beuche & Friede only generated about 20% of the increase in cell density observed during in vivo Wallerian degeneration. A factor may be required for Schwann cell phagocytosis and proliferation which is present in our culture conditions but absent in the model of Beuche & Friede. Alternatively macrophages may be present in our cultures which activate the Schwann cells to phagocytose the myelin. In any case, we agree with the conclusion of Beuche & Friede that Wallerian degeneration is more intricate than previously thought and that further work is needed to clarify the molecular dynamics involved in the process.
The fluorescence surface phenomenon seemed specific for axolemma as myelin and liver microsomes did not interact with the Schwann cells in a similar manner. The suggestion has been made that Schwann cell proliferation during development may be mediated by contact of the cells with the growing axons. Salzer et al. (1980a) showed that Schwann cell proliferation in vitro requires direct.contact with neurite preparations. Our data support the contention that direct axonal contact may facilitate Schwann cell profileration in development. Although some membrane fragments are endocytosed, the mitogenic signal of axolemma is not processed at the lysosomal level, and morphological evidence presented here suggests that the signal may be transduced at the cell surface. Salzer & Bunge (1980) suggested that the stimuli for in vivo Schwann cell proliferation during Wallerian degeneration and neural development may be different. The present study presents morphological evidence that the mitogenic signals of axolemma and myelin are transduced by separate mechanisms. This evidence is corroborated by biochemical studies which have demonstrated that the kinetics of axolemma and myelin-stimulated Schwann cell proliferation are also different; their dose-response curves and the rate at which they stimulate [3H] thymidine uptake into Schwann cells were found to be different by Yoshino et aI. (1984) . The demonstration of distinct mechanisms for the transduction of the mitogenic signals of axolemma and myelin may represent in vitro models for the proliferation of Schwann cells seen in degeneration and development. Efforts are presently being directed at identifying molecular events in the mechanisms of the transduction of the mitogenic signals. We have recently reported on the roles of calcium and cyclic AMP in the mediation of the mitogenic signals of axolemma and myelin .
